•Matador Resources announced that its joint venture San Mateo Midstream has entered a definitive agreement to acquire Cardinal Midstream Partners' operating subsidiaries for $752 million in cash.
•The European Securities and Markets Authority (ESMA) called on unauthorized crypto-asset service providers to wind down their businesses in an orderly manner as the MiCA transitional period ends on July 1.
•The South Korean government announced that Samsung Electronics and SK Hynix will invest in two new chip fabrication sites in the country's southwest region as part of a national project valued at 800 trillion won ($517.87 billion).
•Zymeworks Inc. (Nasdaq: ZYME) has entered into a definitive agreement to acquire Theravance Biopharma, Inc. (Nasdaq: TBPH) for $17.00 per share in cash.
•The transaction represents an equity value of approximately $929 million and includes a contingent value right (CVR) entitling shareholders to 80% of net proceeds from ampreloxetine monetization.
•The transaction is expected to close in the second half of 2026, subject to shareholder approval and customary closing conditions.
•Loopring closed its decentralized exchange due to lack of adoption, citing lack of a virtual machine, composability, and real-world payment use cases.
•AbbVie announced that the CHMP has adopted a positive opinion recommending approval of upadacitinib (RINVOQ) for the treatment of adults and adolescents with severe alopecia areata.
•AYI reported stabilizing lighting demand with AIS delivering double-digit growth, margin strength, and new momentum in controls, OEM channels, and data centers.
•The U.S. Food and Drug Administration has selected Eli Lilly and Regeneron, among seven companies, for a pilot program to accelerate reviews of new domestic pharmaceutical manufacturing facilities.
